http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019535830-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate | 2017-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2019535830-A |
| titleOfInvention | Prevention and / or treatment of contrast-induced acute kidney injury |
| abstract | Provided is a method for preventing, reducing and / or treating contrast-induced acute kidney injury comprising administering an inhibitor of fatty acid oxidation to a patient in need thereof. Also provided is a method comprising the use of trimetazidine or a pharmaceutically acceptable salt thereof for the prevention and / or treatment of contrast-induced acute kidney injury. Also, prevention and / or treatment of contrast-induced acute kidney injury comprising administering trimetazidine, etomoxil, oxphenicin, perhexiline, mildronate or ranolazine or one or more of any of the pharmaceutically acceptable salts thereof Provide a way to do it. |
| priorityDate | 2016-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 76.